Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Burden of disease associated with a COPD eosinophilic phenotype.

International journal of chronic obstructive pulmonary disease - 1 Jan 2018

Ortega Hector, Llanos Jean-Pierre, Lafeuille Marie-Hélène, Germain Guillaume, Duh Mei Sheng, Bell Christopher F, Sama Susan R, Hahn Beth

Abstract excerpt

Purpose: Based on blood and sputum samples, up to 40% of patients with COPD have eosinophilic inflammation; however, there is little epidemiology data characterizing the health care burden within this sub-population. Given that COPD-attributable medical costs in the USA are predicted to approach $50 billion by 2020, we analyzed the effect of blood eosinophil counts and exacerbations on health care resource...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Disease Progression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Eosinophils

Share to Leukocyte Count

Share to Pulmonary Disease, Chronic Obstructive

Share to Time Factors

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 30147308
DOI: 10.2147/COPD.S170995
PMCID: PMC6097826

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Burden of disease associated with a COPD eosinophilic phenotype.PMID 30147308Read ↗

The Burden of COPD with Type 2 Inflammation in North-West Continental Europe.Semantic proximity Read ↗

Chronic obstructive pulmonary disease's eosinophilic phenotype: Clinical characteristics, biomarkers and biotherapy.Semantic proximity Read ↗

Eosinophils in chronic obstructive pulmonary disease.Semantic proximity Read ↗

Mepolizumab for eosinophilic COPD with frequent exacerbations: single-centre real-world experience in a phenotype-directed approach.Semantic proximity Read ↗

Clinical characteristics of eosinophilic asthma exacerbations.Semantic proximity Read ↗

[COPD and phenotypes].Semantic proximity Read ↗

Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic PhenotypeSemantic proximity Read ↗

Burden of illness in blood eosinophilic phenotype COPD patients in New Zealand.Semantic proximity Read ↗

Eosinophilic phenotype was associated with better clinical remission in elderly but not middle-aged patients with acute exacerbations of COPDSemantic proximity Read ↗

Eosinophilic phenotypes of airway disease.Semantic proximity Read ↗

Characterizing ECOPD Phenotypes: Associations with In-Hospital Outcomes and Immunoinflammatory Mechanisms.Semantic proximity Read ↗

Mepolizumab for COPD with Eosinophilic Phenotype following HospitalizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.